Efficacy and Safety of Once-Daily Inhaled Umeclidinium in Asian Patients with COPD: Results from a Randomized, Placebo-Controlled Study.
Nanshan ZhongJin-Ping ZhengSang Haak LeeDavid A LipsonXin DuShunquan WuPublished in: International journal of chronic obstructive pulmonary disease (2020)
Once-daily UMEC 62.5 mcg resulted in statistically significant and clinically meaningful improvements in lung function and dyspnea, compared with placebo, in Asian patients with COPD, with no new safety concerns observed.